currently receive monotherapy treatment with an antiepileptic drug aed at a stable dose for at least 28 day prior to the screening visit visit 1 if the subject be take a barbiturate e.g. phenobarbital the dose must be stable for month prior to the screening visit note subject who have receive previous adjunctive treatment but be currently take one aed be eligible for enrolment 